Bilateral sensorineural hearing loss from danazol therapy. A case report

The Journal of reproductive medicine · 1984 · vol. 29(5) , pp. 351–3 · PMID:6726709 · W2407118224
Case report OA: closed CC0
View on OpenAlex View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-10-12 ⓘ

A case report describes a patient who developed bilateral sensorineural hearing loss from danazol therapy for endometriosis, with prompt resolution following medication withdrawal.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Danazol is a widely used drug that causes few major adverse reactions, most of which are rapidly reversible upon cessation of therapy. While the list of pharmacologic agents capable of causing hearing loss continues to grow, no published reports have ever implicated danazol. We treated a patient for bilateral sensorineural hearing loss due to danazol therapy. The hearing loss resolved promptly after withdrawal of the medication.

My notes (saved in your browser only)

MeSH descriptors

Danazol Hearing Loss Hearing Loss, Bilateral Hearing Loss, Sensorineural Pregnadienes Adult Danazol Danazol Female Hearing Loss Hearing Loss, Bilateral Hearing Loss, Sensorineural Humans Pregnadienes

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-05-11T03:14:06.720737+00:00
pubmed
last seen: 2026-10-08T21:58:20.576574+00:00
License: CC0 · commercial use OK